quinidine has been researched along with Epilepsies, Partial in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abukhalid, M; Abushama, A; Aldhalaan, HM; Alfadhel, M; Almuzaini, HS; Arya, R; Borlot, F; Donner, EJ; Ehaideb, SN; Gowda, VK; Gulati, S; Hershkovitz, T; Jain, P; Jain, V; Konanki, R; Lingappa, L; Luat, AF; Madaan, P; Morrison-Levy, N; Myers, KA; Otsubo, H; Panda, P; Puthenveettil Vinayan, K; Sahu, JK; Sampaio, LPB; Shafi, S; Sharma, S; Simard-Tremblay, E; Tabarki, B; Thomas, M; Whitney, R; Yoganathan, S; Zak, M | 1 |
| Ackermann, S; Ambegaonkar, G; Appleton, R; Chong, WKK; Cross, JH; Desurkar, A; Eltze, C; Gazina, EV; Kneen, R; Kumar, AV; Kurian, MA; Lascelles, K; Malhotra, S; McTague, A; Meyer, E; Montgomery, T; Nair, U; Ngoh, A; Papandreou, A; Petrou, S; Poduri, A; Ramesh, V; Samanta, R; Scheffer, IE; Scott, RH; Tan, J; Topf, M; Trump, N; Whitehouse, W | 1 |
| Fujita, T; Hirose, S; Horino, A; Ikeda, H; Imai, K; Inoue, Y; Ishii, A; Matsumoto, N; Nakashima, M; Oboshi, T; Okanishi, T; Saitsu, H; Takahashi, Y; Yamaguchi, T; Yoshimoto, J; Yoshitomi, S | 1 |
| Bearden, D; DiGiovine, M; Dlugos, D; Ehnot, J; Goldberg, EM; Strong, A | 1 |
| Poduri, A | 1 |
| Chong, PF; Kira, R; Matsumoto, N; Nakamura, R; Saitsu, H | 1 |
| Bearden, D; DiGiovine, M; Dlugos, D; Goldberg, E | 1 |
7 other study(ies) available for quinidine and Epilepsies, Partial
| Article | Year |
|---|---|
KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
Topics: Anticonvulsants; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Diet, Ketogenic; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Genetic Association Studies; Humans; Male; Nerve Tissue Proteins; Potassium Channels, Sodium-Activated; Quinidine; Retrospective Studies | 2020 |
Clinical and molecular characterization of
Topics: Age of Onset; Animals; Anticonvulsants; Child, Preschool; Computer Simulation; Epilepsies, Partial; Genetic Predisposition to Disease; Humans; Infant; Infant, Newborn; Membrane Potentials; Models, Genetic; Models, Molecular; Mutation; Nerve Tissue Proteins; Oocytes; Phenotype; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Sodium-Activated; Quinidine; Structure-Activity Relationship; Xenopus | 2018 |
Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations.
Topics: Anticonvulsants; Arrhythmias, Cardiac; Child; Child, Preschool; Drug Monitoring; Electrocardiography; Epilepsies, Partial; Female; Humans; Infant; Male; Nerve Tissue Proteins; Potassium Channels; Potassium Channels, Sodium-Activated; Quinidine | 2019 |
Targeted treatment of migrating partial seizures of infancy with quinidine.
Topics: Anti-Arrhythmia Agents; Child, Preschool; Dose-Response Relationship, Drug; Electroencephalography; Epilepsies, Partial; Exons; Female; Humans; Mutation, Missense; Nerve Tissue Proteins; Potassium Channels; Potassium Channels, Sodium-Activated; Quinidine; Treatment Outcome | 2014 |
A channel for precision diagnosis and treatment in genetic epilepsy.
Topics: Anti-Arrhythmia Agents; Epilepsies, Partial; Female; Humans; Nerve Tissue Proteins; Potassium Channels; Potassium Channels, Sodium-Activated; Quinidine | 2014 |
Ineffective quinidine therapy in early onset epileptic encephalopathy with KCNT1 mutation.
Topics: Anti-Arrhythmia Agents; Epilepsies, Partial; Female; Humans; Nerve Tissue Proteins; Quinidine | 2016 |
Reply.
Topics: Anti-Arrhythmia Agents; Epilepsies, Partial; Female; Humans; Nerve Tissue Proteins; Quinidine | 2016 |